Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone for IVF outcomes in infertile women
IRCT20230522058253N7Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in female infertility, sponsored by Hamadan University of Medical Sciences. Primary endpoint: chemical pregnancy rate. Started Aug 2025; status: completed.
02
Drugs
somatropin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20230522058253N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230522058253N7.